- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- monomer
- Ligands
- 3 x ZN: ZINC ION(Non-covalent)
- 1 x 1WN: (betaS)-Nalpha-{4-[4-(4-aminophenyl)buta-1,3-diyn-1-yl]benzoyl}-N,beta-dihydroxy-beta-methyl-L-tyrosinamide(Non-covalent)
1WN.4: 17 residues within 4Å:- Chain A: L.18, M.62, E.77, H.78, T.190, F.191, I.197, G.209, S.210, A.214, V.216, H.237, K.238, D.241, H.264
- Ligands: ZN.1, NO3.16
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:L.18, A:T.190, A:F.191, A:F.191, A:I.197, A:I.197, A:A.214, A:V.216
- Hydrogen bonds: A:M.62, A:T.190, A:F.191, A:D.241
- pi-Cation interactions: A:K.238
- 16 x NO3: NITRATE ION(Non-functional Binders)
NO3.5: 8 residues within 4Å:- Chain A: I.158, R.168, T.169, Q.170, D.232, E.233, F.234, V.235
Ligand excluded by PLIPNO3.6: 4 residues within 4Å:- Chain A: I.158, D.159, F.160, K.261
Ligand excluded by PLIPNO3.7: 3 residues within 4Å:- Chain A: M.103, D.104, P.109
Ligand excluded by PLIPNO3.8: 2 residues within 4Å:- Chain A: I.10, R.12
Ligand excluded by PLIPNO3.9: 3 residues within 4Å:- Chain A: R.189, D.226, R.229
Ligand excluded by PLIPNO3.10: 4 residues within 4Å:- Chain A: R.12, A.13, T.14, Y.25
Ligand excluded by PLIPNO3.11: 5 residues within 4Å:- Chain A: Y.230, E.231, D.232, K.236
- Ligands: NO3.14
Ligand excluded by PLIPNO3.12: 3 residues within 4Å:- Chain A: P.148, F.149, D.150
Ligand excluded by PLIPNO3.13: 7 residues within 4Å:- Chain A: E.139, K.142, S.262, G.263, H.264, A.265, L.266
Ligand excluded by PLIPNO3.14: 4 residues within 4Å:- Chain A: E.184, Y.230, K.236
- Ligands: NO3.11
Ligand excluded by PLIPNO3.15: 4 residues within 4Å:- Chain A: T.14, G.15, V.16, K.23
Ligand excluded by PLIPNO3.16: 6 residues within 4Å:- Chain A: T.60, M.62, K.238, G.263, H.264
- Ligands: 1WN.4
Ligand excluded by PLIPNO3.17: 3 residues within 4Å:- Chain A: K.132, R.133, D.279
Ligand excluded by PLIPNO3.18: 3 residues within 4Å:- Chain A: Q.115, S.180, V.182
Ligand excluded by PLIPNO3.19: 3 residues within 4Å:- Chain A: T.285, F.286, E.287
Ligand excluded by PLIPNO3.20: 6 residues within 4Å:- Chain A: F.152, F.176, S.177, P.293, I.294, S.295
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liang, X. et al., Synthesis, Structure, and Antibiotic Activity of Aryl-Substituted LpxC Inhibitors. J.Med.Chem. (2013)
- Release Date
- 2013-08-21
- Peptides
- UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- monomer
- Ligands
- 3 x ZN: ZINC ION(Non-covalent)
- 1 x 1WN: (betaS)-Nalpha-{4-[4-(4-aminophenyl)buta-1,3-diyn-1-yl]benzoyl}-N,beta-dihydroxy-beta-methyl-L-tyrosinamide(Non-covalent)
- 16 x NO3: NITRATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liang, X. et al., Synthesis, Structure, and Antibiotic Activity of Aryl-Substituted LpxC Inhibitors. J.Med.Chem. (2013)
- Release Date
- 2013-08-21
- Peptides
- UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A